Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dikla Shmueli

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JMIR Research Protocols|October 19, 2020
Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort StudyShea M Lemley, Jeffrey D Klausner, Sean D Young, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
Data harmonization within the clinical trials network: Strengths, challenges, and opportunities in the era of generative AIRenae D Schmidt, Raymond R Balise, Sophia T Gonzalez, et al.
Contemporary Clinical Trials|August 14, 2016
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationaleJoshua D Lee, Edward V Nunes, Patricia Novo Mpa, et al.
Journal of Substance Use and Addiction Treatment|April 25, 2026
Comorbidities of substance use: Opportunities realized and future needsJudith Feinberg, Viviana Horigian, Renae Schmidt, et al.
European Journal of Clinical Pharmacology|February 26, 2022
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin geneDavid A Nielsen, Robrina Walker, David P Graham, et al.
JMIR Formative Research|September 23, 2022
Relative Effectiveness of Social Media, Dating Apps, and Information Search Sites in Promoting HIV Self-testing: Observational Cohort StudyChrysovalantis Stafylis, Gabriella Vavala, Qiao Wang, et al.
Contemporary Clinical Trials Communications|June 28, 2019
Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodologyAugust F Holtyn, Eugene Bosworth, Lisa A Marsch, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Trials|January 29, 2021
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus studyNiranjan S Karnik, Cynthia I Campbell, Megan E Curtis, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|October 19, 2020
Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort StudyShea M Lemley, Jeffrey D Klausner, Sean D Young, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
Data harmonization within the clinical trials network: Strengths, challenges, and opportunities in the era of generative AIRenae D Schmidt, Raymond R Balise, Sophia T Gonzalez, et al.
Contemporary Clinical Trials|August 14, 2016
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationaleJoshua D Lee, Edward V Nunes, Patricia Novo Mpa, et al.
Journal of Substance Use and Addiction Treatment|April 25, 2026
Comorbidities of substance use: Opportunities realized and future needsJudith Feinberg, Viviana Horigian, Renae Schmidt, et al.
European Journal of Clinical Pharmacology|February 26, 2022
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin geneDavid A Nielsen, Robrina Walker, David P Graham, et al.
JMIR Formative Research|September 23, 2022
Relative Effectiveness of Social Media, Dating Apps, and Information Search Sites in Promoting HIV Self-testing: Observational Cohort StudyChrysovalantis Stafylis, Gabriella Vavala, Qiao Wang, et al.
Contemporary Clinical Trials Communications|June 28, 2019
Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodologyAugust F Holtyn, Eugene Bosworth, Lisa A Marsch, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Trials|January 29, 2021
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus studyNiranjan S Karnik, Cynthia I Campbell, Megan E Curtis, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Pageof 4